⌘K

Login Start Free

Home/Filings/4/0001104659-23-014610

4//SEC Filing

Maccecchini Maria-Luisa 4

Accession 0001104659-23-014610

CIK 0001477845other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:11 PM ET

Size

6.9 KB

Accession

0001104659-23-014610

Insider Transaction Report

Form 4

Period: 2023-02-06

Annovis Bio, Inc.ANVS

Maccecchini Maria-Luisa

DirectorPresident & CEO

Transactions

Exercise/Conversion
Stock Option (right to buy)
2023-02-06−52,755→ 0 total
Exercise: $0.14Exp: 2027-04-01→ Common Stock (52,755 underlying)
Exercise/Conversion
Common Stock
2023-02-06$0.14/sh+52,755$7,386→ 1,040,489 total

Footnotes (1)

[F1]All of the shares underlying the option are fully vested and exercisable.

Documents

1 file

4
tm231947-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1

filerCIK 0001315018

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 5:11 PM ET
Size: 6.9 KB

View on SEC.gov